Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

MRP1 polymorphisms associated with citalopram response in patients with major depression.

Lee SH, Lee MS, Lee JH, Kim SW, Kang RH, Choi MJ, Park SJ, Kim SJ, Lee JM, Cole SP, Lee MG.

J Clin Psychopharmacol. 2010 Apr;30(2):116-25. doi: 10.1097/JCP.0b013e3181d2ef42.

PMID:
20520284
2.

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH, Smoller JW.

Arch Gen Psychiatry. 2007 Jun;64(6):689-97.

PMID:
17548750
3.

Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.

Binder EB, Owens MJ, Liu W, Deveau TC, Rush AJ, Trivedi MH, Fava M, Bradley B, Ressler KJ, Nemeroff CB.

Arch Gen Psychiatry. 2010 Apr;67(4):369-79. doi: 10.1001/archgenpsychiatry.2010.18.

PMID:
20368512
4.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.

Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P, Souery D, Zohar J, Massat I.

Int Clin Psychopharmacol. 2010 Jul;25(4):218-27. doi: 10.1097/YIC.0b013e328338b884.

PMID:
20531207
5.

Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.

Tsai SJ, Hong CJ, Liou YJ, Chen TJ, Chen ML, Hou SJ, Yen FC, Yu YW.

Psychiatry Res. 2009 Sep 30;169(2):113-7. doi: 10.1016/j.psychres.2008.06.028. Epub 2009 Aug 22.

PMID:
19700204
6.

Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.

Tsai SJ, Hong CJ, Liou YJ, Yu YW, Chen TJ, Hou SJ, Yen FC.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15;33(4):637-41. doi: 10.1016/j.pnpbp.2009.02.020. Epub 2009 Mar 9.

PMID:
19272410
7.

Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors.

Arias B, Serretti A, Mandelli L, Gastó C, Catalán R, Ronchi DD, Fañanás L.

Pharmacogenet Genomics. 2009 Feb;19(2):121-8. doi: 10.1097/FPC.0b013e32831ebb4b.

PMID:
19065121
8.
9.
10.

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.

Kocabas NA, Antonijevic I, Faghel C, Forray C, Kasper S, Lecrubier Y, Linotte S, Massat I, Mendlewicz J, Noro M, Montgomery S, Oswald P, Snyder L, Zohar J, Souery D.

Int Clin Psychopharmacol. 2011 Jan;26(1):1-10.

PMID:
21188787
11.

Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.

Papiol S, Arias B, Gastó C, Gutiérrez B, Catalán R, Fañanás L.

J Affect Disord. 2007 Dec;104(1-3):83-90. Epub 2007 Apr 30.

PMID:
17467808
12.

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.

Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS.

Brain Res. 2006 Nov 6;1118(1):176-82. Epub 2006 Sep 18.

PMID:
16979146
13.
14.

SLC6A4 variation and citalopram response.

Mrazek DA, Rush AJ, Biernacka JM, O'Kane DJ, Cunningham JM, Wieben ED, Schaid DJ, Drews MS, Courson VL, Snyder KA, Black JL 3rd, Weinshilboum RM.

Am J Med Genet B Neuropsychiatr Genet. 2009 Apr 5;150B(3):341-51. doi: 10.1002/ajmg.b.30816.

15.

Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.

Okumura T, Kishi T, Okochi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Tsunoka T, Inada T, Ozaki N, Iwata N.

Neuropsychobiology. 2010;61(2):57-63. doi: 10.1159/000265130. Epub 2009 Dec 12.

PMID:
20016223
16.

Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.

Arias B, Serretti A, Lorenzi C, Gastó C, Catalán R, Fañanás L.

J Affect Disord. 2006 Feb;90(2-3):251-6. Epub 2005 Dec 13.

PMID:
16356553
17.

[Association between polymorphisms of Val66Met in the BDNF gene and the response to escitalopram and nortriptyline treatment in the light of the neurodevelopmental hypothesis of depression].

Rajewska-Rager A, Skibińska M, Szczepankiewicz A, Kapelski P, Dmitrzak-Weglarz M, Leszczyńska-Rodziewicz A, Hauser J.

Psychiatr Pol. 2008 Nov-Dec;42(6):915-23. Polish.

PMID:
19441668
18.

Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.

Choi MJ, Kang RH, Ham BJ, Jeong HY, Lee MS.

Neuropsychobiology. 2005;52(3):155-62. Epub 2005 Aug 25.

PMID:
16127283
19.

Association of angiotensin-converting enzyme gene promoter single nucleotide polymorphisms and haplotype with major depression in a northeastern Thai population.

Angunsri R, Sritharathikhun T, Suttirat S, Tencomnao T.

J Renin Angiotensin Aldosterone Syst. 2009 Sep;10(3):179-84. doi: 10.1177/1470320309344151.

PMID:
19713413
20.

Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.

Perlis RH, Fijal B, Adams DH, Sutton VK, Trivedi MH, Houston JP.

Biol Psychiatry. 2009 May 1;65(9):785-91. doi: 10.1016/j.biopsych.2008.10.002. Epub 2008 Dec 18.

PMID:
19095219
Items per page

Supplemental Content

Write to the Help Desk